Flamel Technologies Launches Akovaz(TM)

LYON, FRANCE--(Healthcare Sales & Marketing Network) - Flamel Technologies ( NASDAQ : FLML ) today announced the launch of Akovaz™, its formulation of ephedrine sulfate for injection, which received approval from the U.S. Food and Drug Administration (FDA)... Biopharmaceuticals, Drug Delivery, Product Launch Flamel Technologies, Akovaz, ephedrine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news